JAMP TEMOZOLOMIDE
Identification of Jamp Temozolomide
| No description |
Google image searchProduct monograph
Active ingredient
temozolomide, 250 MG
DIN: 02516845
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 26-JUL-2022
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01A — ALKYLATING AGENTS (ATC, ATC/DDD)
- L01AX — Other alkylating agents (ATC, ATC/DDD)
- L01AX03 — TEMOZOLOMIDE (ATC/DDD)
Reference brand drug: Temodal
Pharmaceutical standard: MFR
